NIF Ventures

NIF Ventures was a leading Japanese venture capital firm that played a pivotal role in financing early-stage life science and technology companies across Asia and North America. Originally established as Nippon Investment & Finance, the firm rebranded to NIF Ventures and was publicly traded on the JASDAQ exchange before merging with SMBC Capital in 2005 to form NIF SMBC Ventures. The firm focused heavily on high-growth sectors including biotechnology, pharmaceuticals, and medical devices, providing critical capital to startups navigating the Japanese market. Its legacy continues through its successor, Daiwa Corporate Investment, which remains a significant player in healthcare private equity. The firm's historical portfolio includes numerous healthcare entities that achieved successful clinical milestones and public listings.